1. What Is the Connected Diabetes Device Market?
The Connected Diabetes Device Market encompasses smart insulin delivery and glucose monitoring devices with wireless connectivity. These devices transmit real-time data to smartphone apps, cloud platforms, and clinical data management systems for remote monitoring and therapy optimisation. The market includes Bluetooth-enabled smart insulin pens with dose recording and connectivity, connected insulin pumps with remote monitoring capability, cellular and Bluetooth-connected blood glucose meters, and the associated data management connectivity platforms and accessories. These devices are used by people with type 1 and type 2 diabetes to automatically record insulin doses, glucose measurements, and therapy events. This enables their diabetes care teams to remotely review treatment data and intervene before poor glycaemic control leads to complications. Market scope covers hardware diabetes devices with wireless connectivity and their associated data transmission infrastructure. It excludes continuous glucose monitor wearable sensors addressed in the Wearable Glucose Monitor Market and standalone diabetes management software without connected device integration.
2. Connected Diabetes Device Market Size & Forecast
3. Emerging Technologies
- Bidirectional CGM-insulin pump data integration platforms are advancing automated data exchange protocols between CGM receiver apps and connected insulin pump apps that enable unified glucose-insulin dose visualisation, closed-loop algorithm optimisation, and remote. Growing diabetes.
- Smart insulin pen algorithm integration with CGM data is advancing bolus dose recommendation algorithms that access real-time CGM glucose trend data and calculate an optimised mealtime insulin dose accounting for current glucose, trend direction. Growing industry adoption of this technology is motivating development.
- Closed-loop algorithm advancement for hybrid and fully automated insulin delivery is advancing model predictive control and reinforcement learning algorithms that automate 24-hour basal and mealtime insulin delivery based on CGM data without patient. Growing.
- Open-source insulin delivery system ecosystem development is advancing community-developed APS algorithm platforms including Loop and OpenAPS that diabetes technology users build from compatible CGM and pump hardware to create. Growing type 1 diabetes patient.
Such innovations are driving change across adjacent industries too. Discover more in our Diabetes Care Platform Market.
4. Key Market Opportunity
A major opportunity in the Connected Diabetes Device Market is the expansion of smart insulin pen adoption among the large type 2 diabetes multiple daily injection patient population currently using conventional pens without automatic dose recording. A significant proportion of type 2 MDI patients use conventional unconnected pens providing no automatic dose recording, creating reliance on patient diary self-reporting that results in frequent data gaps and poor treatment optimisation. Smart pen caps and integrated connected pens that automatically record and transmit dose and timing data to CGM apps provide complete insulin-glucose data pairing without patient diary entry, enabling more effective remote therapy optimisation. Smart pen manufacturers that develop affordable connected solutions compatible with leading CGM apps, provide clinical evidence of improved glycaemic control from smart pen plus CGM data pairing, and achieve health plan reimbursement are positioned to capture the large type 2 MDI market.
5. Top Companies in the Connected Diabetes Device Market
The following organisations hold leading positions in the Connected Diabetes Device Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Insulet (Omnipod)
- Novo Nordisk (NovoPen)
- Eli Lilly (connected devices)
- Ascensia Diabetes Care
- FORA Care
- Companion Medical (Medtronic)
- Bigfoot Biomedical
- Voluntis
- Dexcom
- Abbott
6. Market Segmentation
The Connected Diabetes Device Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Device Type | Smart Insulin Pen Bluetooth Dose Capture Pen Cap Integrated Smart Pen Connected Insulin Pump Tubeless Patch Pump Traditional Pump with Connectivity Connected BGM Bluetooth Glucose Meter Cellular BGM Smart Insulin Dosing Device Wearable Bolus Advisor Connected Auto-Injector |
| By Connectivity | Bluetooth Low Energy BLE Data Sync Cellular IoT Cellular Real-Time Sync NFC Near Field NFC Tap Transfer Wi-Fi Wi-Fi Direct Meter |
| By Diabetes Type | Type 1 Diabetes T1D Smart Pen and Pump Type 2 Diabetes T2D Smart Pen T2D Connected BGM Gestational Diabetes GDM Connected Monitor |
| By End User | Patients Type 1 Diabetes Self-Managers Type 2 Insulin Patients Healthcare Providers Diabetes Care Teams Remote Monitoring Clinics Payers Digital Disease Management Programmes Employers Employer Digital DM Programme |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Connected Diabetes Device Market trajectory over the forecast period:
Smart Insulin Pen Technology Is Providing Dose Capture and CGM Integration for Multiple Daily Injection Users Previously Excluded from Digital Diabetes Management.Endocrinologists and diabetes nurses managing type 1 and type 2 diabetes patients on multiple daily injection therapy are prescribing smart pen caps and integrated smart insulin pens that automatically record insulin doses with timestamp. These practices include transmit to CGM apps, enabling complete insulin and glucose data pairing for clinical review. Novo Nordisk expanded commercial availability of the NovoPen Echo Plus connected insulin pen with Bluetooth dose recording. LibreView integration in 2024, providing MDI users with an affordable smart pen alternative to conventional injection pens for automatic dose capture without manual diary recording.
Tubeless Patch Insulin Pump Technology Is Expanding Insulin Pump Access to Type 1 and Type 2 Diabetes Patients Unwilling to Accept Conventional Tubed Pump Cannula Systems.Endocrinologists managing type 1 and insulin-requiring type 2 diabetes patients who decline conventional tubed insulin pumps due to tube management burden are prescribing tubeless patch pumps including the Omnipod DASH. Omnipod 5 that adhere directly to the skin and require no external tubing. Insulet Corporation reported consistent Omnipod 5 automated insulin delivery patch pump commercial growth in 2024. International market expansion accelerating as tubeless patch pump awareness and prescribing grew at endocrinology programmes managing type 1 and type 2 diabetes patients.
Connected Blood Glucose Meter Technology Is Maintaining Cellular BGM Relevance for Type 2 Diabetes Patients Preferring Fingerstick Over CGM Wearable Sensor.Primary care physicians and endocrinologists managing type 2 diabetes patients on oral therapy or basal insulin who prefer fingerstick testing are prescribing cellular-connected blood glucose meters that transmit glucose readings directly to clinical platforms. This enables remote monitoring without patient app engagement requirements. Ascensia Diabetes Care and FORA continued development of cellular-connected blood glucose meter products for healthcare programme remote monitoring in 2024. This provides type 2 diabetes management programmes with BGM connectivity options for patients who prefer conventional fingerstick without CGM wearable technology.
For related market intelligence, see the Diabetes Management Software Market.
8. Segmental Analysis
By device type, smart insulin pens dominated the Connected Diabetes Device Market in 2025, driven by the large global MDI diabetes population and growing prescribing of connected pen caps providing automatic dose capture. Endocrinologists and diabetes nurses continue increasing smart insulin pen prescribing as automatic dose recording with CGM integration provides complete insulin-glucose data pairing for remote clinical review. Tubeless patch insulin pumps are the fastest-growing device type, driven by growing type 1 and type 2 diabetes patient preference for patch pump systems that eliminate external pump tubing. Endocrinologists are increasing patch pump prescribing as Omnipod 5 and similar tubeless automated insulin delivery systems demonstrate improved glycaemic outcomes and higher patient satisfaction versus conventional tubed pumps.
By diabetes type, type 1 diabetes dominated the Connected Diabetes Device Market in 2025, driven by the high technology adoption rate and established use of connected pumps and smart pens in closed-loop insulin delivery. Endocrinologists managing type 1 diabetes continue prescribing the highest connected device volumes as every type 1 patient on insulin pump therapy and most CGM users require connected device data management. Type 2 diabetes is the fastest-growing segment, driven by expanding smart insulin pen adoption and connected BGM prescribing for the large type 2 MDI population entering digital diabetes management programmes. Endocrinologists and primary care physicians managing type 2 patients in digital programme enrolment are increasing connected device prescribing as smart pen and cellular BGM provide clinical monitoring data without patient app engagement.
9. Regional Analysis
Regional demand patterns across the Connected Diabetes Device Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Connected Diabetes Device Market in 2025, with a market share of 45.0%. The region's leadership reflects the high type 1 and type 2 diabetes patient population in the United States and Canada, the established market for advanced insulin pumps and CGM devices generating connected device demand, and the concentration of connected diabetes device manufacturers with North American commercial operations. Growing Omnipod patch pump adoption and smart insulin pen prescribing at United States endocrinology programmes are driving connected diabetes device market expansion as digital diabetes management programme contracts require device connectivity data for remote clinical monitoring. Comprehensive United States insurance coverage for insulin pumps and CGM devices and growing payer coverage for connected diabetes management programme devices are enabling consistent connected device reimbursement that drives adoption across insured type 1 and type 2 diabetes populations.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 15.40% during the forecast period. Growing insulin-treated diabetes populations, expanding CGM and insulin pump device adoption, and increasing digital diabetes management programme investment in China, Japan, South Korea, India, and Southeast Asia are creating demand for connected diabetes devices. Growing Japanese and South Korean insulin pump and CGM market penetration rates, combined with expanding digital diabetes management programme reimbursement, are increasing demand for connected smart pen and pump products from endocrinology programmes seeking digital data integration. Growing government digital health investment and diabetes management programme development in China and India are creating public sector demand for connected diabetes devices as government-sponsored digital diabetes programmes specify device connectivity for remote population health monitoring.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Connected Diabetes Device Market was valued at USD 5.21 Bn in 2025 and is projected to reach USD 15.40 Bn by 2034, growing at a CAGR of 12.80% over the 2026–2034 forecast period.
The Connected Diabetes Device Market is projected to grow at a CAGR of 12.80% from 2026 to 2034.
North America dominated the Connected Diabetes Device Market in 2025, with a market share of 45.0%.
The leading companies in the Connected Diabetes Device Market include Insulet (Omnipod), Novo Nordisk (NovoPen), Eli Lilly (connected devices), Ascensia Diabetes Care, FORA Care, Companion Medical (Medtronic), Bigfoot Biomedical, Voluntis, Dexcom, Abbott.
Smart insulin pen technology is providing dose capture and cgm integration for multiple daily injection users previously excluded from digital diabetes management.
By device type, smart insulin pens dominated the Connected Diabetes Device Market in 2025, driven by the large global MDI diabetes population and growing prescribing of connected pen caps providing automatic dose capture.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.